TMEM9B expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.12132525487141E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.67454938804212E-12 |
Normal-vs-Stage2 |
1.45490000003079E-06 |
Normal-vs-Stage3 |
4.44089209850063E-16 |
Normal-vs-Stage4 |
5.55111512312578E-16 |
Stage1-vs-Stage2 |
1.654810E-01 |
Stage1-vs-Stage3 |
1.993500E-02 |
Stage1-vs-Stage4 |
3.966200E-02 |
Stage2-vs-Stage3 |
2.171500E-02 |
Stage2-vs-Stage4 |
2.370500E-02 |
Stage3-vs-Stage4 |
9.741000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.43769498715119E-15 |
Normal-vs-AfricanAmerican |
3.80451226078549E-12 |
Normal-vs-Asian |
1.122770E-03 |
Caucasian-vs-AfricanAmerican |
2.172600E-01 |
Caucasian-vs-Asian |
7.332000E-01 |
AfricanAmerican-vs-Asian |
3.828000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.63713487211226E-12 |
Normal-vs-Female |
1.64135371960583E-12 |
Male-vs-Female |
9.323800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.09919962021365E-10 |
Normal-vs-Age(41-60Yrs) |
1.65423230669148E-14 |
Normal-vs-Age(61-80Yrs) |
1.19904086659517E-14 |
Normal-vs-Age(81-100Yrs) |
5.81469999999529E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.929200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.728600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.042800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.349200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.045600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.929800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.07239999997044E-07 |
Normal-vs-Grade 2 |
2.22377671832419E-13 |
Normal-vs-Grade 3 |
1.62536650805123E-12 |
Normal-vs-Grade 4 |
1.62470037423645E-12 |
Grade 1-vs-Grade 2 |
8.562600E-01 |
Grade 1-vs-Grade 3 |
2.775600E-01 |
Grade 1-vs-Grade 4 |
9.608200E-02 |
Grade 2-vs-Grade 3 |
2.433900E-02 |
Grade 2-vs-Grade 4 |
4.516400E-03 |
Grade 3-vs-Grade 4 |
3.042000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.63147273468667E-12 |
Normal-vs-ccB subtype |
1.62647673107585E-12 |
ccA subtype-vs-ccB subtype |
2.724000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.2854608750531E-14 |
Normal-vs-N1 |
8.78379999846857E-08 |
N0-vs-N1 |
6.839000E-01 |
|
|